Summary & Overview
HCPCS J1271: Injection, Doxycycline Hyclate 1 mg
HCPCS Level II code J1271 denotes an injectable dose of doxycycline hyclate, 1 mg. The code identifies a parenteral antibiotic supply line used in clinical settings where intravenous or intramuscular administration is required. Nationally, accurate use of this code matters for consistent drug billing, inventory tracking, and aggregation of outpatient antimicrobial utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, billing benchmarks, and common clinical contexts for use of an injectable doxycycline formulation.
Readers will learn the clinical context for billing J1271, typical sites of service where injectable doxycycline is administered, and the types of benchmarks and policy issues relevant to drug-administered service lines. The report summarizes national payer coverage considerations and highlights areas where coding clarity affects claims processing and reporting. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1271 represents an injection of doxycycline hyclate, 1 mg. This code is used for billing a parenteral formulation of doxycycline administered by injection.
Service Type: Drug administration (injectable antibiotic)
Typical Site of Service: Outpatient clinic, physician office, hospital outpatient department, or other ambulatory care settings where injectable medications are given.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or clinic for administration of intravenous or intramuscular antibiotic therapy where parenteral doxycycline hyclate is clinically indicated. Common scenarios include treatment of severe community-acquired infections (e.g., atypical pneumonias when oral intake is not possible), tick-borne infections in patients unable to tolerate oral medications, or as part of inpatient antibiotic regimens when enteral access is compromised. The clinical workflow begins with physician evaluation and diagnosis, order entry for J1271 specifying dose in milligrams, verification of allergies and renal/hepatic status by nursing staff, preparation of the injection by pharmacy under aseptic technique, administration by an authorized clinician (RN or physician) with vital signs monitoring, documentation of lot numbers and expiration, and billing using J1271 for the injectable doxycycline product. Observation time varies by indication; if the injection is administered during a visit for a separate evaluation or procedure, appropriate visit or procedure codes may be reported with applicable modifiers to indicate distinct services.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | Use when part of a single-use vial is wasted and documentation supports discarded drug quantity. |